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Neisseria gonorrhoeae is an obligate human path-
ogen and the causative agent of the sexually trans-
mitted disease gonorrhea. The control of this disease
has been compromised by the increasing proportion
of infections due to antibiotic-resistant strains, which
are growing at an alarming rate.N. gonorrhoeaeMtrF
is an integral membrane protein that belongs to the
AbgT family of transporters for which no structural in-
formation is available. Here, we describe the crystal
structure of MtrF, revealing a dimeric molecule with
architecture distinct from all other families of trans-
porters. MtrF is a bowl-shaped dimer with a solvent-
filled basin extending from the cytoplasm to halfway
across the membrane bilayer. Each subunit of the
transporter contains nine transmembrane helices
and two hairpins, posing a plausible pathway for sub-
strate transport. A combination of the crystal struc-
ture and biochemical functional assays suggests
thatMtrF is anantibioticeffluxpumpmediatingbacte-
rial resistance to sulfonamide antimetabolite drugs.
INTRODUCTION
Neisseria gonorrhoeae is a gram-negative diplococcus that is
found only in humans and causes the sexually transmitted dis-
ease gonorrhea. Given that it is a strictly human pathogen and
can colonize both male and female genital mucosal surfaces
and other sites, it has developed mechanisms to overcome anti-
microbial systems of the host’s innate defense. Onemajormech-
anism that N. gonorrhoeae uses to resist antimicrobial agents is
the expression of multidrug efflux pumps that recognize and
actively export a variety of structurally unrelated toxic com-
pounds from the bacterial cell, including antibacterial peptides,long-chain fatty acids, and several clinically important antibiotics
(Lee and Shafer, 1999; Rouquette-Loughlin et al., 2003; Shafer
et al., 1998, 2001; Unemo and Shafer, 2014).
The best characterized efflux system in N. gonorrhoeae is the
MtrC-MtrD-MtrEmultidrugeffluxsystem (Delahayet al., 1997; Lu-
cas et al., 1995;Hagmanet al., 1995, 1997; Veal andShafer, 2003;
Warner et al., 2008). This system is similar to other efflux pumpsof
the resistance-nodulation-cell division (RND) superfamily (Tseng
et al., 1999) possessed by many Gram-negative bacteria. MtrD
(Bolla et al., 2014;Hagmanetal., 1995, 1997;HagmanandShafer,
1995) is the inner membrane transporter component of the tripar-
tite RND pump. The complex is formed by interactions between
MtrD, the periplasmic membrane fusion protein MtrC (Hagman
et al., 1995, 1997; Veal et al., 2002; Janganan et al., 2013), and
the outer membrane channel MtrE (Delahay et al., 1997; Lei
et al., 2014b; Janganan et al., 2011, 2013). This powerful efflux
complex mediates the export of several structurally diverse hy-
drophobic antimicrobial agents, such as antibiotics, nonionic de-
tergents, antibacterial peptides, bile salts, and gonadal steroidal
hormones (Delahayet al., 1997;Hagmanet al., 1995, 1997;Shafer
et al., 1998). In addition, theMtr efflux system includes another in-
ner membrane protein MtrF (Veal and Shafer, 2003; Folster and
Shafer, 2005), which belongs to the AbgT family of transporters
(Prakash et al., 2003). It has been proposed that MtrF cooperates
with the MtrC-MtrD-MtrE complex to export certain antimicro-
bials by a yet-unknown mechanism (Veal and Shafer, 2003).
To date, approximately 13,000 putative transporters of the
AbgT family have been identified. AbgT-type proteins are
commonly found in Gram-negative bacteria such as Salmonella
enterica, Gram-positive bacteria such as Staphylococcus
aureus, as well as yeasts such as Saccharomyces arboricola.
Surprisingly, among proteins in this diverse family, only Escher-
ichia coli AbgT (Hussein et al., 1998; Carter et al., 2007) and
N. gonorrhoeaeMtrF (Folster and Shafer, 2005; Veal and Shafer,
2003) have been partially characterized. Thus far, there is no
structural information available for this family of membrane
proteins, obscuring the details of their function and mechanism.Cell Reports 11, 61–70, April 7, 2015 ª2015 The Authors 61
Figure 1. Structure of the N. gonorrhoeae
MtrF Transporter
(A) Transmembrane topology of N. gonorrhoeae
MtrF. The transporter contains nine transmem-
brane helices (TMs) and two hairpins (HPs).
(B) Ribbon diagram of a dimer of MtrF viewed in
the membrane plane. The right subunit of the
dimer is colored using a rainbow gradient from the
N terminus (blue) to the C terminus (red), whereas
the left subunit is colored gray. The MtrF dimer
forms a bowl-shaped structure with a concave
aqueous basin facing the intracellular solution.
(C) Surface representation of a cross-section of
the MtrF dimer sliced through the middle of the
protein. Each protomer forms an internal cavity
(red arrow), which is accessible to the cytoplasm.
(D) Bottom view of a surface representation of the
MtrF dimer, indicating a solvent accessible cavity
(red circle) from each protomer of the protein. The
two protomers are colored gray and yellow.The products of the E. coli abg genes have been shown to
catalyze the uptake and cleavage of the folate catabolite p-ami-
nobenzoyl-glutamate (Carter et al., 2007). Particularly, E. coli
AbgT has been demonstrated to import the catabolite p-amino-
benzoyl-glutamate for de novo folic acid synthesis (Carter et al.,
2007). As E. coli AbgT and N. gonorrhoeae MtrF belong to the
same family of transporters, there is a chance that the MtrF pro-
tein may also act as an importer to uptake p-aminobenzoyl-
glutamate and related small molecules for the synthesis of the
essential folate vitamin. However, since MtrF is needed for the
high-level resistance of gonococci to hydrophobic antimicro-
bials, including erythromycin and TX-100 (Folster and Shafer,
2005), it seems more likely that it participates in drug efflux. To
understand the transport functions of members of the AbgT fam-
ily, we here present the crystal structure of the N. gonorrhoeae
MtrF transporter. Importantly, we show that N. gonorrhoeae
MtrF is capable of exporting the folate metabolite p-aminoben-62 Cell Reports 11, 61–70, April 7, 2015 ª2015 The Authorszoic acid (PABA) from cells. A combina-
tion of the three-dimensional structure
and genetic analysis allows us to identify
key MtrF residues that are important for
the function of this membrane protein.
Finally, we demonstrate that MtrF be-
haves as an antibiotic efflux pump,
which is responsible for removing sulfon-
amides from the cell and mediating
bacterial resistance to this class of
antimetabolites.
RESULTS AND DISCUSSION
Overall Structure ofN. gonorrhoeae
MtrF
The N. gonorrhoeae MtrF transporter is
composed of 522 amino acids, sharing
38% identity with E. coli AbgT (Figure S1).
The crystal structure of this membraneprotein was determined to a resolution of 3.95 A˚ (Table S1).
Two molecules of MtrF, which assemble as a dimer, are found
in the asymmetric unit (Figure S2; Figure 1). Superimposition of
these two MtrF molecules gives an RMSD of 0.5 A˚ over 506 Ca
atoms, indicating that their conformations are nearly identical
to each other. The dimeric form of MtrF in the crystal lattice is
in good agreement with the oligomerization state of this mem-
brane protein in detergent solution in which it also assembles
as a dimer (Figure S3).
The fold of MtrF is unique and composed of a number of un-
usual structural elements. Each subunit of MtrF comprises nine
a-helical transmembrane segments and two helical hairpins:
TM1 (a [12–22] and b [26–47]), TM2 (a [78–92], b [94–112], and
c [114–125]), HP1 (a [128–145] and b [147–164]), TM3 (a [168–
182] and b [191–205]), TM4 [218–240], TM5 [269–292], TM6
[310–334], TM7 (a [341–353], b [356–374], and c [376–391]),
HP2 (a [396–413] and b [417–434]), TM8 (a [438–451] and b
Figure 2. Inner and Outer Cores of MtrF
(A) The inner core of MtrF, comprising TMs 1, 2, 5, 6, and 7 (colored slate),
contributes to dimerization as well as formation of a frame-like structure
housing the outer core of the protomer. The outer core of MtrF is composed of
TMs 3, 4, 8, 9 as well as HPs 1 and 2 (colored yellow).
(B) The outer core of MtrF forms a channel (colored purple) spanning
approximately from the middle of the inner membrane up to the periplasmic
space. This channel was calculated using the program CAVER (http://
loschmidt.chemi.muni.cz/caver). The secondary structural elements of the
MtrF protomer are in yellow. Residues D193, S417, W420, P438, R446, D449,
and P457 are in green sticks.[462–471]) and TM9 [480–506]). It should be noted that five of
these TMs (TM1, TM2, TM3, TM7, and TM8) are broken into
segments within the membrane. In addition, HP1 and HP2 are
formed by relatively short helices, which are only long enough
to span half of the membrane (Figures 1A and 1B). Interestingly,
the intramembrane loops of several of these TMs and HPs are
right next to each other, allowing the transporter to form an inter-
nal cavity within the membrane (Figures 1C and 1D). Noticeably,
our structure indicates that the N- and C-terminal ends of MtrFare located at different sides of the inner membrane (Figures
1A and 1B). As there was no signaling peptide added when ex-
pressing the MtrF protein, the N-terminal end of this protein
should be located at the cytoplasm. Thus, the C-terminal end
of MtrF should be positioned within the periplasmic space.
This is in good agreement with the predicted E. coli AbgT topol-
ogy that the C-terminal end of this protein is located at the peri-
plasm (Daley et al., 2005).
Each protomer of MtrF contains a relatively small periplasmic
domain. This domain is made up of two long loops formed be-
tween TMs 1 and 2, and TMs 5 and 6, respectively. Below the in-
ner leaflet of the membrane, a small cytoplasmic domain links
TMs 4 and 5 together. This domain comprises a relatively long
random loop and helix (a1) (Figure 1A).
Viewed in parallel to the membrane, the MtrF dimer is bowl
shaped with a concave aqueous basin facing the intracellular so-
lution (Figure 1B). The dimer is about 75 A˚ tall, 80 A˚ wide, and
50 A˚ thick, with the transmembrane portion of the transporter
lying approximately in the middle. The rim of the basin is as large
as 45 A˚. The bowl-shaped structure is 25 A˚ in depth and deeply
penetrates into the inner leaflet of the cytoplasmic membrane
(Figure 1C). This basin probably allows aqueous solution to
reach the midpoint of the membrane bilayer. Interestingly, a
similar bowl-shaped structure has also been found in the gluta-
mate transporter (Yernool et al., 2004). However, the bowl
shape, which deeply penetrates into the membrane, is formed
within the trimer of this transporter (Yernool et al., 2004).
The structure of the MtrF dimer can be roughly divided into the
inner and outer cores (Figure 2). The inner core contains TMs 1,
2, 5, 6, and 7, creating a frame-like structure to house the outer
core of the protein (Figure 2A). A portion of this inner core is
responsible for forming a dimerization domain of the transporter.
Viewed along the membrane normal, TMs 1b, 2a, 2b, 6, 7a, and
7b, as well as their counter parts from the next subunit,
contribute to this distinct dimerization domain.
Noticeably, the outer core of the MtrF protomer, comprising
TMs 3, 4, 8, and 9 as well as HPs 1 and 2, folds into a cylindrical
structural feature (Figure 2A). It is most likely that this outer core
cylinder forms a substrate-binding site and transport pathway.
Based on the crystal structure, the outer core cylinder contrib-
utes to form a tunnel spanning approximately from the middle
of the inner membrane up to the periplasmic space (Figures 2B
and S4). This tunnel is surrounded with HPs 1 and 2, as well as
TMs 3 and 8. Interestingly, this tunnel is connected to the cyto-
plasmic space through an opening located at the basin of the
bowl-shaped structure. The loop regions of HP1, HP2, TM3,
and TM8 form this opening. Several conserved residues,
including D193, S417, W420, P438, R446, D449, and P457, are
found to line the wall of the channel (Figure 2B). These residues
may play an important role for the function.
MtrF Is Capable of Exporting p-Aminobenzoic Acid from
the Cell
As E. coli AbgT has been shown to enable uptake of the folate
catabolite p-aminobenzoyl-glutamate (Carter et al., 2007), we
investigated whether E. coli cells expressing N. gonorrhoeae
MtrF can grow in liquid minimal medium (containing 90.4 mM
Na2HPO4, 22.0 mM KH2PO4, 8.5 mM NaCl, 0.1 mM CaCl2,Cell Reports 11, 61–70, April 7, 2015 ª2015 The Authors 63
Figure 3. Accumulation of Radioactive p-Aminobenzoic Acid
(A) Time course of [3H]-PABA accumulation by E. coli BL21(DE3)DabgTDpabA
double-knockout cells transformed with pET15bUmtrF or pET15b. Cells ex-
pressing mtrF (red curve) show a significant decrease in [3H]-PABA accumu-
lation when compared with cells carrying the empty vector (black curve).
*Values of BL21(DE3)DabgTDpabA/pET15bUmtrF cells that are significantly
different from the control (BL21(DE3)DabgTDpabA /pET15b) values (p < 0.05).
(B) Mutants of the MtrF transporter. Cells possessing the mutant transporter
D193A, W420A, P438A, D449A, and P457A show a significant increase in the
level of [3H]-PABA accumulations compared with cells expressing wild-type
MtrF. However, cells expressing S417A and R446A only show a modest
change on the [3H]-PABA concentration when compared with cells carrying
wild-type MtrF. *Values of BL21(DE3)DabgTDpabA/pET15b and BL21(DE3)
DabgTDpabA cells expressing the mutant transporters that are significantly
higher than that of BL21(DE3)DabgTDpabA/pET15bUmtrF expressing wild-
type MtrF (p < 0.009).
The data showed in (A) and (B) are the cumulative average of three successive
recordings.1.0 mMMgSO4, 20.0 mM NH4Cl, and 22.2 mM glucose) supple-
mented with p-aminobenzoyl-glutamate. Based on several
studies on folic acid transporters (Eudes et al., 2010; Klaus
et al., 2005; Salcedo-Sora et al., 2011), we made an E. coli
knockout strain BL21(DE3)DabgTDpabA that lacks the abgT64 Cell Reports 11, 61–70, April 7, 2015 ª2015 The Authorsgene (Hussein et al., 1998; Carter et al., 2007) to impede uptake
of the catabolite p-aminobenzoyl-glutamate and pabA gene (Ka-
plan and Nichols, 1983) to impair intracellular synthesis of the
metabolite PABA. We then transformed these double-knockout
cells with pET15bUmtrF, expressing N. gonorrhoeae mtrF, or
the empty vector pET15b. Surprisingly, the double-knockout
E. coli BL21(DE3)DabgTDpabA cells, transformed with either
pET15bUmtrF or pET15b, could not grow in this liquid medium
supplemented with p-aminobenzoyl-glutamate up to 1 mM.
However, these cells were capable of growing in liquid minimal
medium when supplemented with 30 nM PABA. Within the
E. coli abg operon, there are two additional genes, abgA and
abgB, located upstream of abgT. The products of these two
genes are the AbgA and AbgB aminoacyl aminohydrolases,
which cleave the catabolite p-aminobenzoyl-glutamate im-
ported by the AbgT transporter to form PABA for folic acid syn-
thesis (Carter et al., 2007). In contrast, the mtr operon of
N. gonorrhoeae does not possess abgA- or abgB-related genes
(www.genome.ou.edu). Thus, our data suggest that MtrF and
AbgT may function differently even though these two membrane
proteins belong to the same family.
Given that PABA is an important precursor for folic acid syn-
thesis, we thought that N. gonorrhoeae MtrF might enable up-
take of PABA. It should be noted that PABA is capable of
diffusing into bacterial cells through the membrane, participating
as an intermediate in de novo synthesis of the essential vitamin
folic acid. Nonetheless, we compared the radioactive PABA
content in cells transformed with either pET15bUmtrF or the
empty vector pET15b. Surprisingly, E. coli cells producing
N. gonorrhoeae MtrF showed a significant decrease in the level
of [3H]-PABA, in contrast to cells transformed with the empty
pET15b vector (Figure 3A). Instead of an importer, the data
strongly suggested to us that MtrF may act as an exporter,
capable of expelling the intracellular PABA metabolite from the
cell.
In order to determine whether the conserved MtrF residues,
D193, S417, W420, P438, R446, D449, and P457, lining the inner
wall of the tunnel formed by each protomer are important for the
function of the transporter, we mutated each residue to alanine,
individually (Table S2). We expressed these mutant transporters
in BL21(DE3)DabgTDpabA. Western analysis suggested that the
expression levels of these mutant transporters are comparable
with that of wild-type MtrF (Figure S5). In addition, western anal-
ysis on the crude cell lysates indicates that the level of expres-
sion of the wild-type MtrF transporter was 200 copies per
cell (Figure S6). In comparison with the expression level of the
AcrB pump, which is 500 copies per cell (Tikhonova and Zgur-
skaya, 2004), the expression level of our MtrF proteins should be
low enough for physiological measurement. We then measured
the accumulation of [3H]-PABA in cells harboring the mutant
transporters, D193A, S417A, W420A, P438A, R446A, D449A,
and P457A. The results showed a significant increase in the
levels of [3H]-PABA accumulation in cells possessing the mutant
transporter D193A, W420A, P438A, D449A, or P457A, when
compared with cells expressing wild-type N. gonorrhoeae MtrF
(Figure 3B). However, cells expressing S417A and R426A only
indicated a modest change in the [3H]-PABA concentration
when compared with cells carrying wild-type MtrF (Figure 3B).
Figure 4. Intracellular Folic Acid Concentration
Folic acid concentration in E. coli BL21(DE3)DabgTDpabA double-knockout
cells expressing MtrF were markedly reduced in comparison with cells
transformed with the empty vector. When transformed with plasmid ex-
pressing the mutant transporter, D193A, S417A, W420A, P438A, D449A, and
P457A, folic acid production was significantly increased in these cells. How-
ever, the level of intracellular folic acid concentration in BL21(DE3)DabgTD
pabA cells expressing R446A was nearly identical to that of the double-
knockout strain carrying wild-typeMtrF. Each bar represents themean of three
separate cultures. *Values of BL21(DE3)DabgTDpabA/pET15b and BL21(DE3)
DabgTDpabA cells expressing the mutant transporters that are significantly
higher than that of BL21(DE3)DabgTDpabA/pET15bUmtrF expressing wild-
type MtrF (p < 0.04).On the contrary, the levels of [3H]-PABA accumulation in cells ex-
pressing the mutants W420A and D449A were nearly the same
as those transformedwith the empty vector, indicating that these
mutant transporters are not functional and cannot export PABA
from cells. The data suggest that MtrF acts as an efflux pump,
and these amino acids are important for its function.
Expression of the MtrF Transporter Decreases
Intracellular Folic Acid Concentration
We hypothesized that N. gonorrhoeae MtrF is capable of cata-
lyzing the efflux of the folate metabolite PABA. If this is the
case, then cells expressing MtrF should show a lower level of
intracellular folic acid concentration. Therefore, we measured
the intracellular folic acid content of these cells microbiologically
using Lactobacillus casei (Wilson and Horne, 1982). Cells were
grown in liquid minimal medium supplemented with 30 nM
PABA. These cells were harvested when the optical density
(OD600 nm) reached 0.5. Cells were disrupted with a French pres-
sure cell. The crude cell lysates were then assayed microbiolog-
ically using L. casei to obtain their folic acid concentrations.
Consistent with the results from PABA accumulation, the folic
acid concentration in cells producing MtrF were markedly
reduced in comparison with cells transformed with the empty
vector (Figure 4). These data further support our hypothesis
that MtrF acts as an efflux pump and participates in exporting
PABA from the cell.We next investigated how residues D193, S417, W420, P438,
R446, D449, and P457 affect the intracellular folic acid concen-
tration. When transformed with plasmids expressing the mutant
transporter W420A, folic acid production was restored in these
cells and the level of intracellular folic acid concentration was
similar to that of the double-knockout strain transformed with
the empty vector (Figure 4). In addition, cells carrying the mu-
tants, D193A, S417A, P438A, D449A, and P457A, indicated a
significant increase in the level of folic acid concentration when
compared with cells expressing wild-type MtrF (Figure 4). Again,
the data indicate that these residues are important for the func-
tion of the MtrF efflux pump. However, for cells expressing
R446A, the intracellular folic acid content was similar to that of
cells carrying the wild-type MtrF transporter.
MtrF Is an Antibiotic Efflux Pump
As PABA is an important metabolite for producing the essential
folic acid in bacteria, we questioned why the function of MtrF ap-
pears to be decreasing the intracellular PABA concentration. We
postulated that the answer may lie in the ability of MtrF to protect
bacterial cells by extruding antimetabolites that are structurally
similar to PABA, specifically sulfonamides. Sulfonamides are
antimicrobial agents, sometimes referred to as antimetabolites
or growth factor analogs, which are designed to specifically
inhibit the essential metabolic pathway for folic acid synthesis
in bacterial pathogens. At the chemical level, sulfonamides
are structurally similar to the metabolite PABA, making them
ideal competitive inhibitors. Sulfonamides were used in the late
1930s and early 1940s to treat gonorrhea, but the rapid emer-
gence of strains resistant to this class of drug resulted in its
removal once penicillin became available (Unemo and Shafer,
2014); resistant strains were later found to contain mutations in
folP that encodes the target for sulfonamides. We therefore sus-
pect that MtrF may be a drug efflux pump, which is capable of
recognizing and extruding sulfonamide antimetabolites. In fact,
we found that the minimum inhibitory concentration (MIC) of sul-
fanilamide for theN. gonorrhoeae strainWV16 (anmtrF knockout
strain) differed from that of the N. gonorrhoeae parental strain
FA140 by 2-fold (MIC of 250 versus 500 mg/ml, respectively).
To determine whether MtrF behaves like a sulfonamide efflux
pump, we used E. coli as a surrogate host. We transformed
BL21(DE3)DabgTDpabA with pET15bUmtrF or pET15b and
tested for the susceptibility of these transformants to four
different sulfonamide antimetabolites, sulfamethazine, sulfadia-
zine, sulfathiazole, and sulfanilamide (Table S3). It is important
to stress that inmany instances expression of drug efflux pumps,
including members of the RND (Tseng et al., 1999; Li et al., 1995;
Rosenberg et al., 2000) and multidrug and toxic compound
extrusion (MATE) superfamilies (Brown et al., 1999; Long et al.,
2008; Rouquette-Loughlin et al., 2003), can have only modest
changes (2-fold) in bacterial susceptibility to certain anti-
microbials, while more significant changes in susceptibility to
other agents can be observed in the same system. We found
that the BL21(DE3)DabgTDpabA cells producing MtrF were
32-fold less sensitive to sulfamethazine when compared with
BL21(DE3)DabgTDpabA cells containing the empty pET15b vec-
tor. In addition, this BL21(DE3)DabgTDpabA/pET15bUmtrF
transformant was found to be eight times more resistant toCell Reports 11, 61–70, April 7, 2015 ª2015 The Authors 65
Figure 5. Accumulation of Radioactive Sulfamethazine
E. coli BL21(DE3)DabgTDpabA cells expressing MtrF show a significant
decrease in [3H]-sulfamethazine accumulation when compared with cells
carrying the empty vector. When transformed with plasmids expressing the
mutant transporters, D193A, S417A, W420A, P438A, R446A, D449A, and
P457A, the levels of intracellular [3H]-sulfamethazine accumulation were much
higher than that of cells expressing wild-type MtrF. Each bar represents the
mean of three different cultures. *Values of BL21(DE3)DabgTDpabA/pET15b
and BL21(DE3)DabgTDpabA cells expressing the mutant transporters that
are significantly higher than that of BL21(DE3)DabgTDpabA/pET15bUmtrF
expressing wild-type MtrF (p < 0.001).sulfanilamide in comparison to the double-knockout cells trans-
formed with pET15b. We also found that the MICs of BL21(DE3)
DabgTDpabA/pET15bUmtrF cells for sulfadiazine and sulfathia-
zole were both greater than eight times than those of BL21(DE3)
DabgTDpabA cells carrying the empty vector pET15b. These
data indeed indicate that MtrF functions as a drug efflux pump
and reduced bacterial susceptibility to sulfonamides.
The binding affinities of these four sulfonamide drugs, sulfa-
methazine, sulfadiazine, sulfathiazole, and sulfanilamide, as
well as PABA for the MtrF transporter were then determined us-
ing isothermal titration calorimetry (ITC). The data indicate that
the dissociation constants,KDs, for sulfamethazine, sulfadiazine,
sulfathiazole, sulfanilamide, and PABA bindings are 0.33 ± 0.02,
12.74 ± 0.62, 1.52 ± 0.07, 1.14 ± 0.01, and 0.54 ± 0.02 mM,
respectively (Figure S7; Table S4). These ligand-binding experi-
ments indeed confirm that MtrF is capable of recognizing these
ligands.
In order to further test the drug efflux capability of MtrF, we ex-
pressed themutant transporters D193A, S417A,W420A, P438A,
R446A, D449A, and P457A in BL21(DE3)DabgTDpabA and eval-
uated for their ability to confer sulfamethazine, sulfadiazine, sul-
fathiazole, and sulfanilamide resistance. Inmost cases, we found
that strain BL21(DE3)DabgTDpabA carrying these MtrF mutants
are more sensitive to sulfamethazine and sulfanilamide in com-
parison with cells expressing wild-type MtrF (Table S3). With
the exception of the R446 variant, our data indicate that strain
BL21(DE3)DabgTDpabA carrying the MtrF mutants were hyper-66 Cell Reports 11, 61–70, April 7, 2015 ª2015 The Authorssensitive to sulfadiazine and sulfathiazole in comparison with
cells expressing wild-type MtrF (Table S3). These data indeed
agree with the idea that these residues are essential for the func-
tion of MtrF.
To confirm these drug-susceptibility testing results, we
measured the accumulation of radioactive sulfonamide in
BL21(DE3)DabgTDpabA cells carrying pET15bUmtrF or pET15b.
For these experiments, we compared the accumulation of [3H]-
sulfamethazine over time in these cells. As shown in Figure 5,
the results indicate a much lower level of [3H]-sulfamethazine
accumulation in BL21(DE3)DabgTDpabA cells producing MtrF,
compared to controlled cells harboring the empty pET15b vector,
suggesting that MtrF is capable of exporting sulfamethazine from
the cell.
When transformedwith plasmids expressing themutant trans-
porters, D193A, S417A, W420A, P438A, R446A, D449A, and
P457A, the level of intracellular sulfamethazine accumulation
were much higher than that of cells expressing wild-type MtrF
(Figure 5). Again, these data indicate that residues D193, S417,
W420, P438, R446, D449, and P457 are critical for the function
of the MtrF efflux pump.
In addition, we determined the binding affinities of sulfametha-
zine, sulfadiazine, sulfathiazole, sulfanilamide, and PABA for the
W420A mutant transporter using ITC. The data depict that the
KDs, for sulfamethazine, sulfadiazine, sulfathiazole, sulfanil-
amide and PABA bindings are 10.78 ± 1.17, 105.82 ± 25.60,
50.76 ± 8.90, 6.80 ± 1.49, and 41.15 ± 11.50 mM, respectively
(Table S5). These bindings are much weaker than those of
wild-type MtrF, suggesting that residue W420 is critical for the
function of the protein.
MtrF Behaves as a PMF-Dependent Drug Efflux Pump
It has been suggested that members of the AbgT family use
the proton-motive-force (PMF) to transport substrates across
the membrane (Prakash et al., 2003). To elucidate whether
N. gonorrhoeae MtrF is a PMF-dependent transporter, we
measured the level of intracellular sulfamethazine accumulation
in the presence of carbonyl cyanide m-chlorophenylhydrazone
(CCCP), a de-coupler of the membrane proton gradient. After
the addition of CCCP into the assay solution, the accumulation
of [3H]-sulfamethazine increased drastically in theMtrF-express-
ing cells (Figure 6A), suggesting the possibility that MtrF is PMF
dependent.
We then investigated the accumulation level of radioactive sul-
famethazine in strain BL21(DE3)DabgTDpabA/pET15bUmtrF in
the presence of NaCl or KCl. The concentrations of these metal
ions were either 5 or 100 mM. In all cases, the levels of accumu-
lation of [3H]-sulfamethazine were similar to that in the MtrF-pro-
ducing strain without the addition of any metal ions (Figures 5
and 6A), indicating that the function of MtrF is independent of
Na+ or K+.
The drug accumulation data strongly suggest that MtrF is a
PMF-dependent efflux pump. To test this possibility, we next
measured the efflux of [3H]-sulfamethazine that had accumu-
lated in strain BL21(DE3)DabgTDpabA/pET15bUmtrF over
time, both in the absence and presence of Na+. Cells were first
loaded with [3H]-sulfamethazine and CCCP was added to inhibit
the pump. Cells were then re-energized by removing CCCP and
Figure 6. Transport of Sulfamethazine via MtrF
(A) Accumulation of radioactive sulfamethazine in BL21(DE3)DabgTDpabA/
pET15bUmtrF cells with different sodium or potassium ion concentrations. The
data indicate that the transport function of MtrF is independent of sodium or
potassium ions.
(B) Efflux of radioactive sulfamethazine in BL21(DE3)DabgTDpabA/pET15-
bUmtrF cells in the absence and presence of sodium ions. The presence of
Na+ does not affect [3H]-sulfamethazine efflux in BL21(DE3)DabgTDpabA/
pET15bUmtrF cells (black, controlled cells transformed with empty vector;
red, 0mMNaCl; blue, 5mMNaCl). *Values of radioactive counts of intracellular
[3H]-sulfamethazine in BL21(DE3)DabgTDpabA/pET15bUmtrF cells with 0mM
NaCl (red) (p < 0.003) and 5 mM NaCl (p < 0.001) that are significantly different
from those of the control (black).
The data showed in (A) and (B) are the cumulative average of three successive
recordings.adding glucose; thereafter, radioactive measurements were per-
formed both in the absence and presence of 5 mM NaCl. As
shown in Figure 6B, the addition of Na+ essentially has no effect
on sulfamethazine efflux in BL21(DE3)DabgTDpabA/pET15-
bUmtrF. These data suggest that MtrF is a PMF-dependent
efflux pump.Conclusions
In this paper,we report thecrystal structure of theN.gonorrhoeae
MtrF transporter, which reveals a dimeric molecule with a fold
very distinct from all other families of transporters. Our experi-
mental data strongly suggest that N. gonorrhoeae MtrF is a
drug efflux pump, capable of removing sulfonamide antimetabo-
lites and mediating resistance to this class of drugs in bacterial
cells. It is likely that many members of the AbgT family of trans-
porters may serve as antimetabolite efflux pumps to protect cells
against these noxious agents.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of N. gonorrhoeae MtrF
Briefly, the full-length MtrF membrane protein containing a 6xHis tag at the N
terminus was overproduced in E. coli BL21(DE3)DacrB cells, which harbor a
deletion in the chromosomal acrB gene, possessing pET15bUmtrF. Cells
were grown in 12 l of Luria broth (LB) medium with 100 mg/ml ampicillin at
25C. When the OD600 nm reached 0.5, the culture was treated with 0.2 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) to induce mtrF expression, and
cells were harvested within 15 hr. The collected bacteria were resuspended
in buffer containing 100 mM sodium phosphate (pH 7.2), 10% glycerol,
1 mM ethylenediaminetetraacetic acid (EDTA) and 1 mM PMSF and then dis-
rupted with a French pressure cell. The membrane fraction was collected and
washed twice with buffer containing 20 mM sodium phosphate (pH 7.2), 2 M
KCl, 10% glycerol, 1 mM EDTA, and 1 mM PMSF and once with 20 mM
HEPES-NaOH buffer (pH 7.5) containing 1 mM PMSF as described previously
(Long et al., 2010). The membrane protein was then solubilized in 2% (w/v) n-
dodecyl-b-D-maltoside (DDM). Insoluble material was removed by ultracentri-
fugation at 100,0003 g. The extracted protein was purified with a Ni2+-affinity
column. The purified protein was dialyzed and concentrated to 20 mg/ml in a
buffer containing 20 mM Na-HEPES (pH 7.5) and 0.05% DDM. The 6xHis tag
at the N terminus was then cleaved by adding 5 U of thrombin (GE Healthcare)
per mg of purified MtrF at room temperature for 20 hr. The protein was sub-
sequently passed through a Ni2+-affinity column to remove the free 6xHis tag.
A final purification step was performed using a G200 size exclusion column
loaded with buffer solution containing 20 mM Na-HEPES (pH 7.5) and
0.05% DDM. The purity of the MtrF protein (> 95%) was judged using 10%
SDS-PAGE stained with Coomassie brilliant blue. The purified protein was
then concentrated to 20 mg/ml in a buffer containing 20 mM Na-HEPES
(pH 7.5) and 0.05% DDM.
For 6xHis selenomethionyl-substituted (SeMet)-MtrF protein expression, a
10 ml LB broth overnight culture containing E. coli BL21(DE3)DacrB/pET15-
bUmtrF cells was transferred into 120 ml of LB broth containing 100 mg/ml
ampicillin and grown at 37C. When OD600 nm value reached 1.2, cells were
harvested by centrifugation at 6,000 rev/min for 10 min and then washed
two timeswith 20ml of M9minimal salts solution. The cells were re-suspended
in 120 ml of M9 media and then transferred into a 12 l pre-warmedM9 solution
containing 100 mg/ml ampicillin. The cell culture was incubated at 25C with
shaking. When OD600 nm reached 0.4, 100 mg/l of lysine, phenylalanine, and
threonine, 50 mg/l isoleucine, leucine, and valine, and 60 mg/l of L-selenome-
thionine were added. The culture was induced with 0.2 mM IPTG after 15 min.
Cells were then harvested within 15 hr after induction. The procedures for pur-
ifying SeMet-MtrF were identical to those of the native protein.
Crystallization of MtrF
Crystals of the MtrF transporter were obtained using vapor diffusion. The MtrF
crystals were grown at room temperature with the following procedures. A 2-ml
protein solution containing 20 mg/ml MtrF protein in 20 mM Na-HEPES (pH
7.5) and 0.05% (w/v) DDM was mixed with a 2 ml of reservoir solution contain-
ing 30% PEG 400, 0.1 M sodium acetate (pH 5.0), 0.1 M magnesium acetate,
3% glycerol, and 1% (w/v) octyl glucose neopentyl glycol (OGNG). The resul-
tant mixture was equilibrated against 500 ml of the reservoir solution. The crys-
tallization conditions for SeMet-MtrF were the same as those for native MtrF.
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month. Typically, the dimensions of the crystals were 0.23 0.23 0.2 mm. Cry-
oprotection was achieved by raising the PEG 400 concentration to 32%.
Crystals of the Ta6Br12
2+ orW6(m-O)6(m-Cl)6Cl6
2 cluster derivative were pre-
pared by incubating the crystals of MtrF in solution containing 32% PEG 400,
0.1 M sodium acetate (pH 4.6), 0.05 M magnesium acetate, 5% glycerol, 1%
(w/v) OGNG, 0.05% (w/v) DDM, and 0.5 mM Ta6Br12
2Br (Jena Bioscience) or
0.5 mM (NH4)2W6(m-O)6(m-Cl)6Cl6 for 4 hr at 25
C.
Data Collection, Structural Determination, and Refinement
All diffraction data were collected at 100K at beamline 24ID-C located at the
Advanced Photon Source, using a Pilatus 6M detector (Dectris). Diffraction
data were integrated using DENZO and scaled using SCALEPACK (Otwinow-
ski and Minor, 1997). Crystals of MtrF belong to space group P65 (Table S1).
Based on the molecular weight of MtrF (56.3 kDa), two molecules per asym-
metric unit with a solvent content of 71.9% were expected. Data from a native
crystal, two heavy-atom derivatives, namely, Ta6Br12
2+ and W6(m-O)6(m-Cl)6-
Cl6
2 clusters, and a selenomethionyl-substituted (SeMet) crystal were used
for phase determination (Table S1). Four tantalum (Ta6Br12
2+) cluster sites
were identified using SHELXD (Schneider and Sheldrick, 2002) as imple-
mented in the HKL2MAP package (Pape and Schneider, 2004). These
heavy-atom sites were refined using the program AutoSol in PHENIX (Adams
et al., 2002). These phases were then used to locate six tungsten cluster sites
using the corresponding W6(m-O)6(m-Cl)6Cl6
2 data set. Multiple isomorphous
replacement with anomalous scattering (MIRAS), including data from the
tantalum and tungsten complexes, was performed at a resolution of 5.70 A˚ us-
ing AutoSol implemented in PHENIX (Adams et al., 2002). These phases were
then subjected to density modification, NCS averaging, and phase extension
to native 3.95-A˚ resolution using the program RESOLVE (Terwilliger, 2001).
Density-modified phases were good enough to visualize the secondary struc-
tural features of the protein molecule.
After tracing the initial model manually using the program Coot (Emsley and
Cowtan, 2004), molecular replacement with single wavelength anomalous
diffraction (MR-SAD) was performed, utilizing the SeMet data, using the
program Phaser (McCoy et al., 2007). The full-length MtrF protein contains
30 methionines (excluding the first N-terminal methionine residue), all of these
corresponding 30 selenium sites were found in the difference Fourier map. The
electron density map was further improved by multi-crystal averaging,
including the two different crystal forms (both SeMet and wild-type) of the
MtrF dimer, using PHENIX (Adams et al., 2002).
Themodel was then rebuilt and refined against the native data at 3.95 A˚-res-
olution using PHENIX (Adams et al., 2002), leaving 5% of reflections in Free-R
set. Feature-enhanced maps calculated using PHENIX and B-factor sharp-
ening maps created using CCP4 were employed to ascertain loop-regions
and side chains in the structure. Iterations of refinement using PHENIX (Adams
et al., 2002) and CNS (Bru¨nger et al., 1998) and model building in Coot (Emsley
and Cowtan, 2004) lead to the current structural model of the MtrF transporter
(Table S1). The sulfur atom positions of all 30 methionines coincide with their
corresponding Se peaks in the anomalous map.
Gel Filtration
A protein liquid chromatography Superdex 200 16/60 column (GE Healthcare)
with a mobile phase containing 20 mM Na-HEPES (pH 7.5) and 0.05% (w/v)
DDM was used in the gel filtration experiments. Blue dextran (Sigma-Aldrich)
was used to determine the column void volume. As there are no commercially
available membrane protein markers, we used the well-characterized
N. gonorrhoeae NorM multidrug efflux pump (Lu et al., 2013; Long et al.,
2008) (which exists as a monomer in solution with the monomeric molecular
weight equals 50.6 kDa) and E. coli CusC outer membrane channel (Kulathila
et al., 2011; Lei et al., 2014a) (which exists as a trimer in solutionwith the trimeric
molecular weight equals 147.7 kDa) as standards. The experiments were
repeated for three times. Gel filtration suggested an average molecular weight
of 112.1 ± 4.1 kDa for the MtrF transporter (Figure S3). This value is in good
agreement with the theoretical value of 112.5 kDa for two MtrF protomers.
Construction of the Double-Knockout Strain
The double-knockout E. coli strain BL21(DE3)DabgTDpabA was produced
from the BL21(DE3) strain using an RED disruption system as described68 Cell Reports 11, 61–70, April 7, 2015 ª2015 The Authorsby Datsenko and Wanner (2000). The DabgT::kan cassette, which was
used to replace the chromosomal abgT gene, was produced by PCR and
then introduced into pKD46/BL21(DE3) by electroporation. The knockout
BL21(DE3)DabgT::kan strain was selected on LB plate containing 30 mg/ml
kanamycin and verified by PCR. The kanamycin-resistant gene was then
released to generate the BL21(DE3)DabgT knockout strain. The deletion of
pabA from BL21(DE3)DabgT was done using similar procedures as
described above to generate the final BL21(DE3)DabgTDpabA double-
knockout strain.
Site-Directed Mutagenesis
We performed site-directed mutagenesis on residues D193, S417, W420,
P438, R446, D449, and P457 to generate single point mutants D193A,
S417A, W420A, P438A, R446A, D449A, and P457A. The primers used for
these mutations are listed in Table S2. All oligonucleotides were purchased
from Integrated DNA Technologies in a salt-free grade.
Accumulation Assays of p-Aminobenzoic Acid
In brief, E. coli BL21(DE3)DabgTDpabA carrying pET15bUmtrF or pET15b
were grown in LB broth with 100 mg/ml ampicillin at 37C. When OD600 nm
reached 0.5, the culture was treated with 0.2 mM IPTG to inducemtrF expres-
sion, and cells were harvested within 2 hr. Cells were washed twice with
buffer containing 50 mM potassium phosphate (pH 7.5), twice with buffer
containing 100 mM Tris-HCl (pH 7.5), and then suspended in the same buffer
to OD600 nm of 15. [
3H]-PABA (Moravek Biochemicals) was then added to a
final concentration of 0.3 mM. Samples of 100 ml were taken at intervals,
applied directly to prewetted glass-fiber filters, and washed twice with 5-ml
aliquots of the same buffer; 0.5-mm glass-fiber filters (MFS) were used with
a filter apparatus. Filters were then incubated for 30 min in scintillation fluid
(ScintiVerse BD) and counted with a Packard Tri-Carb 1600TR liquid scintilla-
tion counter (PerkinElmer). For [3H]-PABA accumulations in cells expressing
the MtrF mutants, the procedures for sample preparation were the same as
above.
Assays of Folic Acid
The concentration of folic acid in the double-knockout BL21(DE3)DabgTD
pabA strain transformed with pET15bUmtrF or pET15b was measured using
Lactobacillus casei based on the microbiological procedure of Wilson and
Horne (1982). The concentrations of folic acid in BL21(DE3)DabgTDpabA ex-
pressing the mutant transporters were measured using the same procedures.
Drug-Susceptibility Assays
The susceptibilities to various drugs of E. coli BL21(DE3)DabgTDpabA
harboring pET15bUmtrF expressing the wild-type or mutant transporters, or
the pET15b empty vector were tested on agar plates. Cells were grown in Lu-
ria broth (LB) medium with 100 mg/ml ampicillin at 37C. When OD600 nm
reached 0.5, the cultures were induced with 0.2 mM IPTG and harvested
in 2 hr after induction. TheMICs to sulfamethazine, sulfadiazine, sulfathiazole,
and sulfanilamide of E. coli BL21(DE3)DabgTDpabA (incoculum, 500 cells/ml)
harboring these vectors were then determined using LB agar containing
50 mg/ml ampicillin, 0.1 mM IPTG, and different concentrations of these
drugs.
For the MIC studies with N. gonorrhoeae cells, we used strains FA140 and
WV16 (as FA140 but mtrF::kan) described by Veal and Shafer (2003). These
strains were grown on GCB agar plates. The susceptibilities to sulfanilamide
were performed using the agar dilution assay described by Hagman et al.
(1995).
Isothermal Titration Calorimetry
We used ITC to examine the binding of a variety of ligands to the purified MtrF
transporter. Measurements were performed on a VP-Microcalorimeter (Micro-
Cal) at 25C. Before titration, the protein was thoroughly dialyzed against
buffer containing 20 mM Tris-HCl (pH 7.5) and 0.03% DDM. The protein con-
centration was determined using the Bradford assay. The protein sample was
then adjusted to a final monomeric concentration of 40 mM. Ligand solution
consisting of 1.0 mM sulfamethazine, sulfadiazine, sulfathiazole, sulfanil-
amide, or PABA in 20 mM Tris-HCl (pH 7.5) and 0.03% DDM was prepared
as the titrant. The protein and ligand samples were degassed before they were
loaded into the cell and syringe. Binding experiments were carried out with the
protein solution (1.5ml) in the cell and the ligand as the injectant. Ten-microliter
injections of the ligand solution were used for data collection.
Injections occurred at intervals of 300 s, and the duration time of each injec-
tion was 20 s. Heat transfer (mcal/s) was measured as a function of elapsed
time (s). The mean enthalpies measured from injection of the ligand in the
buffer were subtracted from raw titration data before data analysis with
ORIGIN software (MicroCal). Titration curves were fitted by a nonlinear least-
squares method to a function for the binding of a ligand to a macromolecule.
Nonlinear regression fitting to the binding isotherm provided us the equilibrium
binding constant (KA = 1/KD). Calorimetry trials were also carried out in the
absence of MtrF in the same experimental conditions. No change in heat
was observed in the injections throughout the experiment.
Accumulation Assays of Sulfamethazine
The procedures for [3H]-sulfamethazine accumulation were the same as
those for [3H]-PABA accumulation. Cells were incubated with 75 nM [3H]-
sulfamethazine (Moravek Biochemicals) for 15 min, applied directly to pre-
wetted glass-fiber filters, and washed immediately twice with 5-ml aliquots
of the same buffer. Filters were then incubated for 30 min in scintillation
fluid (ScintiVerse BD) and counted with a Packard Tri-Carb 1600TR liquid
scintillation counter (PerkinElmer). For metal ion dependent experiments,
cells were incubated with 75 nM [3H]-sulfamethazine in the presence of
NaCl or KCl (5 or 100 mM) for 15 min and then applied directly to prewetted
glass-fiber filters and washed immediately twice with 5-ml aliquots of
buffer containing 100 mM Tris-HCl (pH 7.5) and 5 or 100 mM salt (NaCl
or KCl).
Efflux Assays of Sulfamethazine
E. coli BL21(DE3)DabgTDpabA carrying pET15bUmtrF or pET15b were grown
in LB broth with 100 mg/ml ampicillin at 37C. When OD600 nm reached 0.5, the
culture was induced with 0.2 mM IPTG, and cells were harvested within 2 hr.
Cells were washed twice with buffer containing 50 mM potassium phosphate
(pH 7.5), twice with buffer containing 100 mM Tris-HCl (pH 7.5) and then sus-
pended in the same buffer to OD600 nm of 15. CCCP was added to the cell sus-
pension at a final concentration of 100 mM. Cells were then incubated for
10 min, pelleted, washed twice, and resuspended in the same buffer to
OD600 nm of 10. [
3H]-sulfamethazine was then added to a final concentration
of 37 nM. Cells were incubated for 15 min, and a final concentration of 0.2%
glucose was then added to the cell suspension. When needed, a final concen-
tration of 5 mM NaCl was also added at the same time. At various time points,
samples of 100 ml were applied directly to prewetted glass-fiber filters, and
washed twice with 5-ml aliquots of buffer containing 100 mM Tris-HCl (pH
7.5). Filters were then incubated for 30 min in scintillation fluid (ScintiVerse
BD) and counted with a Packard Tri-Carb 1600TR liquid scintillation counter
(PerkinElmer).
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